ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
Holders of 5% or more of PMN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ProMIS Neurosciences Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Sclar Jeremy M. | 13G/A | 16.90%9.51M shares | – | Oct 15, 20251 filing | Oct 15, 2025 | SEC |
| ABG Management Ltd. | 13D | 11.30%6.07M shares | −0.50 ppfrom 11.80% | Aug 4, 20252 filings | Oct 29, 2025 | SEC |
| Shaf QIC LLC | 13G/A | 10.01%10.5M shares | – | Jul 31, 20251 filing | Jul 31, 2025 | SEC |
| Great Point Partners LLC | 13G/A | 9.99%5.97M shares | 0.00 ppfrom 9.99% | Feb 14, 20253 filings | Nov 14, 2025 | SEC |
| Gordon Michael S | 13G/A | 9.00%4.89M shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| Armistice Capital, LLC | 13G/A | 5.53%2.97M shares | −1.61 ppfrom 7.14% | Feb 14, 20253 filings | Nov 14, 2025 | SEC |
| Sphera Funds Management Ltd. | 13G/A | 5.51%3.12M shares | – | Oct 23, 20251 filing | Oct 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on ProMIS Neurosciences Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20256:26 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 5.53%2.97M shares | −1.61 ppfrom 7.14% | Sep 30, 2025 | SEC |
| Nov 14, 20252:12 PM ET | Great Point Partners LLCand 2 others | 13G/A | 9.99%5.97M shares | 0.00 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Oct 29, 20254:30 PM ET | ABG Management Ltd.and 3 others | 13D | 11.30%6.07M shares | −0.50 ppfrom 11.80% | Oct 22, 2025 | SEC |
| Oct 23, 20256:02 AM ET | Sphera Funds Management Ltd.and 2 others | 13G/A | 5.51%3.12M shares | – | Sep 30, 2025 | SEC |
| Oct 15, 20255:24 PM ET | Sclar Jeremy M.and 2 others | 13G/A | 16.90%9.51M shares | – | Sep 30, 2025 | SEC |
| Aug 14, 20255:12 PM ET | Great Point Partners LLCand 2 others | 13G/A | 9.99%3.33M shares | 0.00 ppfrom 9.99% | Jun 30, 2025 | SEC |
| Aug 14, 20254:20 PM ET | Gordon Michael Sand 1 other | 13G/A | 9.00%4.89M shares | – | Jun 30, 2025 | SEC |
| Aug 4, 20255:55 PM ET | ABG Management Ltd.and 3 others | 13G | 11.80%6.06M shares | New | Jul 29, 2025 | SEC |
| Jul 31, 20259:36 PM ET | Shaf QIC LLCand 1 other | 13G/A | 10.01%10.5M shares | – | Jul 29, 2025 | SEC |
| May 15, 20253:37 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 7.14%2.33M shares | −0.54 ppfrom 7.68% | Mar 31, 2025 | SEC |
| Feb 14, 20255:17 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 7.68%2.51M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:39 PM ET | Great Point Partners LLCand 2 others | 13G/A | 9.99%3.33M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ProMIS Neurosciences Inc. shares.
No Form 144 notices for ProMIS Neurosciences Inc. are on file.